ETFs
R
RPRX
Royalty Pharma Plc
50.00
+1.52+3.14%After Hours: 50.00 0.00 0.00%19:34 04/17 EDT
OPEN/PREV CLOSE48.60/48.48
TODAY RANGE48.35-50.00
VOL3.04M
MARKET CAP28.85B
52 WEEK RANGE30.85-50.00
AVG VOL (3M)3.50M
% TURNOVER0.53%
TURNOVER--
P/E (TTM)28.07
% RANGE3.40%
EPS(TTM)1.781
P/E(FORWARD)14.37
P/B4.455
BVPS11.22
DIVIDEND0.9400
P/S12.13
BETA--
DIV YIELD1.88%
FREE FLOAT MKT CAP20.63B
SHARES OUTSTANDING576.94M
NEXT EARNINGS05/06-05/11
FREE FLOAT412.69M
LOT SIZE1
EX-DATE05/15/2026
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Royalty Pharma declares $0.235 dividend
Seeking Alpha·5d ago
Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside
Reuters·04/10 20:14
Royalty Pharma announces annual shareholder meeting
Dow Jones·04/10 16:05
Royalty Pharma Is Maintained at Overweight by Morgan Stanley
TipRanks·04/10 13:01
Royalty Pharma price target raised to $63 from $61 at Morgan Stanley
TipRanks·04/10 12:20
Wall Street Analysts Are Bullish on Top Healthcare Picks
Simply Wall St·04/09 01:29
Assessing Royalty Pharma (RPRX) Valuation After Johnson & Johnson Autoimmune Co Funding Deal
Same Industry
Name/Symbol
Change%
Price